Product portfolio

easypharm sells generic products, with special focus on neurology and psychiatry. Our goal is the continuous expansion of our existing portfolio, in order to offer a complete range of relevant products in these segments.



Additionally, easypharm will offer
selected generics in certain therapeutic areas, where they are used for treatments on a regular basis:


Lipid reducers
Proton pump inhibitors
Antibiotics
Antithrombotics
Analgesics, etc.

We are also pursuing close partnerships with makers of
established and proven products. We plan to re-launch these “classic” products with innovative and pro-active marketing initiatives.

Our current portfolio includes:
Eucarbon®, Biocarbon® und Migradon®

 
 
Endlich Linderung bei Hämorrhoiden

HemoClin® ist ein kühlendes Gel zur Linderung und Vorbeugung bei Hämorrhoiden und Analbeschwerden.

img_hemoclin_small

> mehr
 
Finally a new solution against cold sore

easypharm is now offering Erazaban® with the patented active ingredient Docosanol

Erazaban

> more
 
Vantas® – ein Jahres-Implantat zur Therapie des Prostatakarzinoms.

Ab sofort steht eine neue Möglichkeit zur palliativen Therapie des Prostatakarzinoms zur Verfügung.

vantas_logo_solo_2

> mehr
 
Effective help with erektile dysfunction
easypharm ist presenting a new PDE-5 blocker

einfachmannsein.at
Read more...
 
easypharm and MSD cooperate

MSD

easypharm and MSD cooperate in detailing several established products...
Read more...
 
EUCARBON - an efficient digestion regulator

Eucarbon


Stress, the lack of exercise, or an irregular/unusual diet – these can often lead to digestive problems. Typical symptoms are constipation, hard stools, the feeling of blockage in the digestive system, diarrhea, flatulence and nausea. EUCARBON utilizes its multi-level medicinal properties to act as a mild laxative and helps regulate the intestinal tract. It contains only vegetable and mineral substances and helps provides a better state of health.
EUCARBON is available without a prescription from your pharmacy.
Read more...